Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection

• Status: Completed
• Trial end date: 2013-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Gastric cancer radical surgery related complications are common.Somatostatin is a conventional medical therapy for bleeding.This study explore the effect of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node dissection.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: First Affiliated Hospital, Sun Yat-Sen University
• Treatments: Somatostatin

Criteria

Inclusion Criteria:

1. More than eighteen years old

2. Gastric cancer diagnosed by pathological examination

3. Be given informed consent

4. Without diabetes/hyperthyroidism/Damages of functions of heart, liver and kidney/Systemic Infection/immunodeficiency

Exclusion Criteria:

1. Contraindication of vascular puncture operation

2. Patients who refused to take part in the programe

3. Poor compliance of treatment

4. Malnutrition,BMI<18

5. with pancreatectomy